# Stran & Company, Inc.: overview

SWAGW · Nasdaq · CIK 1872525 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/swagw.md) · [Financials](/companies/swagw/financials.md) · [Filings](/companies/swagw/filings.md) · [Insiders](/companies/swagw/insiders.md)

Latest reported revenue: [$33.4m](/filings/0001213900-26-087791.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-087791).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.1](/filings/0001213900-25-109289.md) | [27.0 d](/filings/0001213900-26-034104.md) | [28.7](/filings/0001213900-26-055112.md) | [32.6](/filings/0001213900-26-087791.md) | [26.0](/filings/0001213900-25-109289.md) | [28.9 d](/filings/0001213900-26-034104.md) | [31.2](/filings/0001213900-26-055112.md) | [33.4](/filings/0001213900-26-087791.md) |
| Gross margin | % | [29.5%](/filings/0001213900-25-109289.md) | [32.5% d](/filings/0001213900-26-034104.md) | [29.6%](/filings/0001213900-26-055112.md) | [30.3%](/filings/0001213900-26-087791.md) | [27.2%](/filings/0001213900-25-109289.md) | [30.4% d](/filings/0001213900-26-034104.md) | [30.9%](/filings/0001213900-26-055112.md) | [30.0%](/filings/0001213900-26-087791.md) |
| Operating margin | % | [(10.8%)](/filings/0001213900-25-109289.md) | [(3.5%) d](/filings/0001213900-26-034104.md) | [(1.9%)](/filings/0001213900-26-055112.md) | [1.2%](/filings/0001213900-26-087791.md) | [(6.9%)](/filings/0001213900-25-109289.md) | [(0.1%) d](/filings/0001213900-26-034104.md) | [2.1%](/filings/0001213900-26-055112.md) | [0.3%](/filings/0001213900-26-087791.md) |
| Net margin | % | [(10.1%)](/filings/0001213900-25-109289.md) | [(2.2%) d](/filings/0001213900-26-034104.md) | [(1.4%)](/filings/0001213900-26-087791.md) | [2.0%](/filings/0001213900-26-087791.md) | [(4.8%)](/filings/0001213900-25-109289.md) | [0.8% d](/filings/0001213900-26-034104.md) | [2.4%](/filings/0001213900-26-087791.md) | [0.9%](/filings/0001213900-26-087791.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001213900-25-109289.md) | not reported | [(0.02)](/filings/0001213900-26-055112.md) | [0.03](/filings/0001213900-26-087791.md) | [(0.07)](/filings/0001213900-25-109289.md) | not reported | [0.04](/filings/0001213900-26-055112.md) | [0.02](/filings/0001213900-26-087791.md) |
| Free cash flow | $m | [(2.9) d](/filings/0001213900-25-109289.md) | [1.2 d](/filings/0001213900-26-034104.md) | [(6.0)](/filings/0001213900-26-055112.md) | [6.3 d](/filings/0001213900-26-087791.md) | [(5.9) d](/filings/0001213900-25-109289.md) | [0.0 d](/filings/0001213900-26-034104.md) | [1.2](/filings/0001213900-26-055112.md) | [0.4 d](/filings/0001213900-26-087791.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [39.7](/filings/0001213900-23-024610.md) | [57.9](/filings/0001213900-25-005516.md) | [76.0](/filings/0001213900-25-031596.md) | [82.7](/filings/0001213900-26-034104.md) | [116](/filings/0001213900-26-034104.md) |
| Gross margin | % | [29.8%](/filings/0001213900-23-024610.md) | [26.6%](/filings/0001213900-25-005516.md) | [32.7%](/filings/0001213900-25-031596.md) | [31.2%](/filings/0001213900-26-034104.md) | [29.5%](/filings/0001213900-26-034104.md) |
| Operating margin | % | [(1.1%)](/filings/0001213900-23-024610.md) | [(6.2%)](/filings/0001213900-25-005516.md) | [(1.7%)](/filings/0001213900-25-031596.md) | [(5.9%)](/filings/0001213900-26-034104.md) | [(1.7%)](/filings/0001213900-26-034104.md) |
| Net margin | % | [0.6%](/filings/0001213900-23-024610.md) | [(6.0%)](/filings/0001213900-25-005516.md) | [(0.5%)](/filings/0001213900-25-031596.md) | [(5.0%)](/filings/0001213900-26-034104.md) | [(0.6%)](/filings/0001213900-26-034104.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001213900-23-024610.md) | [(0.18)](/filings/0001213900-25-005516.md) | [(0.02)](/filings/0001213900-25-031596.md) | [(0.22)](/filings/0001213900-26-034104.md) | [(0.04)](/filings/0001213900-26-034104.md) |
| Free cash flow | $m | [(5.7)](/filings/0001213900-23-024610.md) | [(2.6)](/filings/0001213900-25-005516.md) | [(3.5)](/filings/0001213900-25-031596.md) | [2.2](/filings/0001213900-26-034104.md) | [(5.5)](/filings/0001213900-26-034104.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/swagw/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $1.7m | 756,482 |  | Added +259,068 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $609.3k | 273,239 |  | Added +5,934 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $433.4k | 194,331 |  | Reduced −20,400 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $228.5k | 102,465 |  | Reduced −9,606 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $216.4k | 97,030 |  | Reduced −26,896 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $166.6k | 74,712 |  | Unchanged |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $133.4k | 59,800 |  | Unchanged |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $131.0k | 58,750 |  | New +58,750 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $128.1k | 57,424 |  | Unchanged |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $51.4k | 23,056 |  | Added +576 |

## Recent filings

[All 271 filings](/companies/swagw/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-25 | 06:02 ET | [8-K](/filings/0001213900-26-093216.md) | 5.07 Shareholder vote results | 0001213900-26-093216 |
| 2026-08-11 | 16:30 ET | [8-K](/filings/0001213900-26-087819.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-087819 |
| 2026-08-11 | 16:16 ET | [10-Q](/filings/0001213900-26-087791.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087791 |
| 2026-08-06 | 08:30 ET | [8-K](/filings/0001213900-26-085930.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-085930 |
| 2026-07-15 | 16:30 ET | [DEF 14A](/filings/0001213900-26-078345.md) | Proxy statement, period 2026-08-24 | 0001213900-26-078345 |
| 2026-05-12 | 16:31 ET | [8-K](/filings/0001213900-26-055117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-055117 |
| 2026-05-12 | 16:30 ET | [10-Q](/filings/0001213900-26-055112.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055112 |
| 2026-05-08 | 08:30 ET | [8-K](/filings/0001213900-26-053579.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-053579 |
| 2026-03-25 | 16:32 ET | [8-K](/filings/0001213900-26-034107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-034107 |
| 2026-03-25 | 16:31 ET | [10-K](/filings/0001213900-26-034104.md) | Annual report, period 2025-12-31 | 0001213900-26-034104 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-034104.md), filed Mar 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e8125d63-d6fb-45ab-9107-cbe708fdc333)

## About the filer

- CIK: 1872525
- Tickers: SWAG, SWAGW
- Exchange: Nasdaq
- SIC code: 7311 Services-Advertising Agencies
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.